KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours - Debiec-Rychter, M; Sciot, R; Le Cesne, A (Eur J Cancer, 2006)
, et al; EORTC Soft Tissue and Bone Sarcoma Group; Italian Sarcoma Group; Australasian GastroIntestinal Trials Group.